J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online ahead of print on 4 June 2009 as doi:10.1099/jmm.0.006825-0
Journal of Medical Microbiology 2009;58:845.

J Med Microbiol (2009), DOI: 10.1099/jmm.0.006825-0
© 2009 Society for General Microbiology
This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow All Versions of this Article:
jmm.0.006825-0v1
58/7/845    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Dong, Z. W.
Right arrow Articles by Li, M. Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, Z. W.
Right arrow Articles by Li, M. Y.
Agricola
Right arrow Articles by Dong, Z. W.
Right arrow Articles by Li, M. Y.

Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin and neuraminidase genes

Zhang Wei Dong1, Li Wan Yi1, Li Yan2, Li Hong1, Wang Bao Ning1, Wang Feng Ping1, Zhu Yuan Jun1, Jiang Zhong Hua1, Zhong Li1 and Ming Yuan Li1,3

1 West China School of Preclinical and Forensic Medicine, Sichuan University;

2 State Key Laboratory of Oral Diseases, Sichuan University

3 E-mail: zxllmyus{at}yahoo.com

Received September 23, 2008
Accepted March 8, 2009

The high variability of influenza virus brings the difficulties to control and prevent from influenza, thus seeking a promising approach is a hot subject. Haemagglutinin (HA) and neuraminidase (NA) are major surface antigens of the influenza virus and provide effective protection against the lethal challenges with this virus. We constructed a DNA vaccine (pHA-IRES2-NA) with a co-expression of both HA and NA and compared its protective efficacy and immunogenic ability with that of a single-expression of either HA or NA, and the mixture of two single-expressions. Our findings showed that both HA and NA proteins expressed by pHA-IRES2-NA could be detected in vivo and vitro. The protections of DNA vaccines were evaluated by the serum antibody titers, residual lung virus titers, and survival rates of the mice. In murine model, immunization of pHA-IRES2-NA generated significant anti-HA and NA antibody, increased the percent of CD8+ cells and IFN-{gamma}-producing CD8+ cells and ratio of Th1/Th2, which was comparable to the effects of immunization with HA or NA DNA alone and the mixture of HA and NA DNA. All the mice inoculated by pHA-IRES2-NA resisted to the lethal challenge by homologous influenza virus and survived in accompany with low lung virus titer. In addition, previous studies reported the co-expression allowed higher-frequency transduction compared to co-transduction of separated vector systems encoding different genes. The novel co-expressing HA and NA DNA vaccine is a successful alternative in place of the use with the mixture of purified HA and NA proteins or HA and NA DNA.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.